Increased C282Y Heterozygosity in Gestational Diabetes

Background: Hereditary hemochromatosis is an autosomal recessive disorder of iron metabolism that is characterized by excess accumulation of iron in various organs and often leads to diabetes mellitus (DM). To study whether mutations in the hemochromatosis gene (HFE) could be a risk factor for the development of gestational diabetes mellitus (GDM), the prevalence of HFE mutations in patients with GDM was compared to that of healthy pregnant controls. Methods: GDM was diagnosed in 208 of 2,421 pregnant woman screened between the 24th and 28thweek of gestation over a period of 18 months. Patients and 170 matched control subjects were screened for the HFE gene mutations C282Y and H63D. Results: In North and Central European GDM patients, the allele frequency of the C282Y mutation (7.7%) was higher than in pregnant controls (2.9%; p = 0.04), while the frequency of the H63D mutation was not different (p = 0.45). Three patients with GDM were homozygous for H63D (3.1%), 1 patient was homozygous for C282Y (1.0%), 2 patients were compound heterozygous (2.0%) and 26 were heterozygous [11 C282Y (11.2%) and 15 H63D (15.3%)]. C282Y and H63D allele frequencies were not different between controls and GDM patients of Southern European or non-European origin. Irrespective of the HFE-mutation status, serum ferritin levels were increased in patients with GDM compared to healthy pregnant controls (p = 0.01), while transferrin saturation was similar in both groups. Conclusions: In North and Central European patients with GDM, the C282Y allele frequency is higher than in healthy pregnant women, suggesting a genetic susceptibility to the development of GDM.

[1]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. , 2002, Diabetes care.

[2]  P. Stål,et al.  Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls , 2002, Gut.

[3]  M. Worwood,et al.  Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). , 2002, Blood.

[4]  B. Bacon,et al.  Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. , 2002, Journal of hepatology.

[5]  J. Dooley,et al.  Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. , 2002, Journal of hepatology.

[6]  M. Mattioli,et al.  Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. , 2001 .

[7]  W. Burke,et al.  HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. , 2001, American journal of epidemiology.

[8]  D. Cucinotta,et al.  Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. , 2001, Liver.

[9]  S. Yip,et al.  The C282Y mutation of the HFE gene is not found in Chinese haemochromatotic patients: multicentre retrospective study. , 2000, Hong Kong medical journal = Xianggang yi xue za zhi.

[10]  Jennifer J. Pointon,et al.  Geography of HFE C282Y and H63D mutations. , 2000, Genetic testing.

[11]  L. Powell,et al.  Haemochromatosis in the new millennium. , 2000, Journal of hepatology.

[12]  E. Ford,et al.  Diabetes and serum ferritin concentration among U.S. adults. , 1999, Diabetes care.

[13]  J. Dooley,et al.  A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. , 1999, Gastroenterology.

[14]  B. Bacon,et al.  Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. , 1999, The Journal of laboratory and clinical medicine.

[15]  P. Adams.  Population screening for hemochromatosis , 1999, Hepatology.

[16]  C. Datz,et al.  The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. , 1999, Gastroenterology.

[17]  C. Datz,et al.  Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? , 1998, Clinical chemistry.

[18]  T. Scholl.  High Third‐Trimester Ferritin Concentration: Associations With Very Preterm Delivery, Infection, and Maternal Nutritional Status , 1998, Obstetrics and gynecology.

[19]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[20]  C. Datz,et al.  Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. , 1997, Journal of hepatology.

[21]  G. Pacini,et al.  Pronounced Insulin Resistance and Inadequate β-cell Secretion Characterize Lean Gestational Diabetes During and After Pregnancy , 1997, Diabetes Care.

[22]  T. Lakka,et al.  Body Iron Stores Are Associated With Serum Insulin and Blood Glucose Concentrations: Population study in 1,013 eastern Finnish men , 1997, Diabetes Care.

[23]  R. Goldenberg,et al.  Plasma ferritin and pregnancy outcome. , 1996, American journal of obstetrics and gynecology.

[24]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[25]  R. Goldenberg,et al.  Serum Ferritin: A Predictor of Early Spontaneous Preterm Delivery , 1996, Obstetrics and gynecology.

[26]  F. Martin,et al.  The 75 g oral glucose tolerance in pregnancy. , 1995, Diabetes research and clinical practice.

[27]  K. Amankwah,et al.  Gestational diabetes diagnostic criteria: long-term maternal follow-up. , 1995, American journal of obstetrics and gynecology.

[28]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: an expanded clinical entity. , 1994, Gastroenterology.

[29]  B. Legras,et al.  Increased serum ferritin in insulin-dependent diabetes mellitus: relation to glycemic control. , 1994, Clinical chemistry.

[30]  K. Batts,et al.  Liver iron stores in patients with non-insulin-dependent diabetes mellitus. , 1994, Mayo Clinic proceedings.

[31]  D. Simonson,et al.  Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. , 1993, Journal of diabetes and its complications.

[32]  P. Damm,et al.  Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus , 1992, American journal of obstetrics and gynecology.

[33]  J. Hoofnagle,et al.  Measurements of iron status in patients with chronic hepatitis. , 1992, Gastroenterology.

[34]  A. Pawashe,et al.  Hyperferritinemia in pregnancy induced hypertension and eclampsia. , 1992, Journal of postgraduate medicine.

[35]  J. O'sullivan.  Diabetes Mellitus After GDM , 1991, Diabetes.

[36]  P. Adams,et al.  Clinical presentation of hemochromatosis: a changing scene. , 1991, The American journal of medicine.

[37]  P. A. Weiss.  Gestational Diabetes: A Survey and the Graz Approach to Diagnosis and Therapy , 1988 .

[38]  A. Sonnenberg,et al.  Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. , 1985, The New England journal of medicine.

[39]  G. Pozza,et al.  Serum ferritin in type I diabetes. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[40]  L. Powell,et al.  Hemochromatosis and Other Iron Storage Disorders , 1984 .

[41]  H. Zimmerman.  Hepatology: A textbook of liver disease:By D. Zakim and T. D. Boyer. 1318 pp., $95.00. W. B. Saunders Company, Philadelphia, Pennsylvania, 1982 , 1983 .